Group 1 - The stock price of Koyuan Pharmaceutical (301281) closed at 36.95 yuan on August 1, 2025, down 3.58% with a turnover rate of 9.41% and a trading volume of 64,800 hands, amounting to 244 million yuan [1] - The latest financial report for Koyuan Pharmaceutical shows total revenue of 111 million yuan for Q1 2025, a year-on-year decrease of 23.98%, while net profit attributable to shareholders was 23.08 million yuan, an increase of 7.25% [1] - The company has a current ratio of 6.622, a quick ratio of 5.235, and a debt-to-asset ratio of 12.23% [1] Group 2 - Koyuan Pharmaceutical has made investments in 5 companies and participated in 108 bidding projects [2] - The company holds 3 trademark registrations and 65 patents, along with 81 administrative licenses [2]
科源制药（301281）8月1日主力资金净流出2172.59万元